Three-dimensional Noncoplanar Conformal Radiation Therapy With Middle Fraction Dose for the Treatment of Stage I Non-small Cell Lung Cancer

被引：0
|
作者：
Karasawa, K. [1 ]
Okano, N. [1 ]
Machitori, Y. [1 ]
Shimizuguchi, T. [1 ]
Onozawa, M. [1 ]
Murata, H. [1 ]
Izawa, H. [1 ]
Chang, T. [1 ]
Hanyu, N. [1 ]
Nihei, K. [1 ]
机构：
[1] Tokyo Metro Komagome Hosp, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.1608
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S603 / S603
页数：1
相关论文
共 50 条
  • [41] Therapy for stage I and stage II non-small cell lung cancer
    Tanoue, LT
    Ponn, RB
    [J]. CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 173 - +
  • [42] Three-dimensional Non-coplanar Conformal Radiotherapy for the Treatment of Stage I Non-small Cell Lung Cancer: Is it Equally Safe and Effective for So-called Central Tumors?
    Karasawa, K.
    Okano, N.
    Kubo, N.
    Fukayama, M.
    Tagawa, Y.
    Mitsui, N.
    Kuga, G.
    Chang, T.
    Hanyu, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S501 - S501
  • [43] Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy
    Yorke, ED
    Jackson, A
    Rosenzweig, KE
    Merrick, SA
    Gabrys, D
    Venkatraman, ES
    Burman, CM
    Leibel, SA
    Ling, CC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02): : 329 - 339
  • [44] A comparison of intensity-modulated and three-dimensional conformal radiotherapy plans in dose-escalated patients with stage III Non-Small Cell Lung Cancer
    Roa, W
    Amanie, J
    Robinson, D
    Murray, B
    Field, C
    Warkentin, B
    Stavrey, P
    Hennig, R
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S12 - S13
  • [45] Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control
    Mehta, Niraj
    King, Christopher R.
    Agazaryan, Nzhde
    Steinberg, Michael
    Hua, Amanda
    Lee, Percy
    [J]. PRACTICAL RADIATION ONCOLOGY, 2012, 2 (04) : 288 - 295
  • [46] Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy
    Piotrowski, T
    Matecka-Nowak, M
    Milecki, P
    [J]. NEOPLASMA, 2005, 52 (01) : 56 - 62
  • [47] A Phase I Dose Escalation Study using Three-dimensional Conformal Radiotherapy with Concurrent Cisplatin and S-1 in Patients with Stage III Non-small Cell Lung Cancer
    Kozuka, T.
    Harada, H.
    Nishio, M.
    Murakami, H.
    Ohyanagi, F.
    Ishikura, S.
    Horiike, A.
    Morota, M.
    Nishimura, T.
    Yamamoto, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S473 - S474
  • [48] Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer
    Jing Cheng
    [J]. Oncology and Translational Medicine, 2008, (06) : 311 - 314
  • [49] Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study
    Sakaguchi, Masakuni
    Maebayashi, Toshiya
    Aizawa, Takuya
    Ishibashi, Naoya
    Fukushima, Shoko
    Abe, Osamu
    Saito, Tsutomu
    [J]. RADIATION ONCOLOGY, 2016, 11
  • [50] Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study
    Masakuni Sakaguchi
    Toshiya Maebayashi
    Takuya Aizawa
    Naoya Ishibashi
    Shoko Fukushima
    Osamu Abe
    Tsutomu Saito
    [J]. Radiation Oncology, 11
12345